Osteoporosis - teriparatide
Applications for teriparatide are no longer processed by the Complex Drugs Program.
All applications may now be made to the general Authority Prescription Applications 24 Hour Service
- PBS - Free call 1800 888 333
- RPBS – Free call 1800 552 580
To ensure the eligibility of patients can be fully assessed, a comprehensive list of toxicity descriptors is available. This should be used in conjunction with the application when demonstrating a patient's inability to tolerate anti-resorptive therapies. The intolerance must be of a severity to necessitate permanent treatment withdrawal.
- Anti-resorptive agent toxicity and severity descriptors [PDF, 32Kb]
- Anti-resorptive agent toxicity and severity descriptors [RTF, 237Kb]
Important: the information on this website is correct at the time of publishing and is subject to change.
Some documents on this page may require the free Adobe PDF reader.
Last updated: 27 September, 2013